Clinical Research Facility

Wauwatosa, Wisconsin 53226

We've found

2 trials

at this facility

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Wauwatosa, WI

Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis

Status: Enrolling, Phase II, III
Updated: 5/2/2016

from

Wauwatosa, WI

Use our guide to learn which trials are right for you!